ZimVie, Zimmer Biomet's spine and dental company, reached a milestone with its Mobi-C cervical disc implant, the devicemaker said Jan. 30.
More than 200,000 Mobi-C discs have been implanted, according to a news release. The disc has been used in patients across more than 25 countries. The first case was completed in 2004 in France, and in 2013, Mobi-C became the first cervical disc to earn FDA approval for more than one level.
The FDA found Mobi-C was "statistically superior" to spinal fusion at seven years for two-level disc replacement, and at 10 years, patient-reported outcomes were the same or better from seven years.
"Having participated in the Mobi-C investigational device exemption study over a decade ago, I am encouraged that disc replacement has become an emerging standard of care for patients with cervical disc degeneration," spine surgeon Armen Khachatryan, MD, said in the release. ZimVie’s dedication to this space has enabled so many patients to benefit from the technology …. I sincerely hope that this transition from fusion to motion preserving disc replacement technology will not only continue but accelerate in the coming years."